Guideline-changing trial results released earlier in 2019 suggest that SGLT2 inhibitors could be a viable treatment solution for patients with diabetes and evidence of kidney damage.
Pharmacists must embrace pharmacogenetic services before other professions beat them to it Subscription
Multidisciplinary genetic testing services will help patients receive more targeted medicines, and pharmacists are the obvious healthcare professional to lead them.
The new English Desprescribing Network will bring together healthcare professionals and researchers to stamp out medicine-related harm.
The rates of opioid misuse and related deaths may be lower in the UK than in the United States, but healthcare professionals should remain vigilant when caring for patients with chronic pain.
HbA1c targets that ignore differences in the physiology of older patients put them at risk of severe hypoglycaemia, harm and death.